Abstract:
SUMMARY
Impaired insulin secretion in type 2 diabetes (T2D) is linked to reduced insulin granule docking, disorganization of the exocytotic site, and an impaired glucose-dependent facilitation of insulin exocytosis. We show in b-cells from 80 human donors that the glucose-dependent amplification of exocytosis is disrupted in T2D. Spatial analyses of granule fusion, visualized by total internal reflection fluorescence (TIRF) microscopy in 24 of these donors, demonstrate that these are non-random across the surface of b-cells from donors with no diabetes (ND). The compartmentalization of events occurs within regions defined by concurrent or recent membrane-resident secretory granules. This organization, and the number of membraneassociated granules, is glucose-dependent and notably impaired in T2D b-cells. Mechanistically, multi-channel Kv2.1 clusters contribute to maintaining the density of membrane-resident granules and the number of fusion 'hotspots', while SUMOylation sites at the channel N-(K145) and C-terminus (K470) determine the relative proportion of fusion events occurring within these regions. Thus, a glucose-dependent compartmentalization of fusion, regulated in part by a structural role for Kv2.1, is disrupted in b-cells from donors with type 2 diabetes.
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HIGHLIGHTS
• Exocytosis of secretory granules is non-random across the surface of human b-cells, and this organization is disrupted in type 2 diabetes.
• Increasing glucose facilitates the spatial compartmentalization of fusion, independent of an overall increase in event frequency.
• Compartmentalized 'hotspots' occur at sites marked by membrane-associated granules, the density of which is regulated in part by a clustered K + channel (Kv2.1).
• SUMOylation status of the channel controls the proportion of events that occur within these local regions.
INTRODUCTION
Insulin, secreted from pancreatic islet b-cells, is a critical regulator of blood glucose and energy homeostasis in humans (1) . Impaired insulin secretion is a hallmark of type 2 diabetes (T2D) which results from a complex interplay between reduced insulin sensitivity and impaired insulin secretion (2) . A tipping point occurs when secretion from genetically predisposed b-cells fails to meet the demands of peripheral insulin resistance (3, 4) . While impaired insulin responses in T2D may result from a long-term reduction in b-cell mass (5), reduced secretory function likely predominates at earlier stages (6, 7) . In isolated islets or b-cells from donors with T2D in vitro, exocytotic protein expression is reduced (8, 9) and exocytotic responses are impaired (10, 11) .
Most recently this has been attributed to an impaired glucose-dependent granule docking and reduced expression of docking and related active zone proteins (12) .
While b-cells lack ultra-structurally identifiable active zones, glucose-stimulation in situ triggers fusion events that are progressively localized to preferential release sites (13) . These appear directed towards the islet vasculature (13) (14) (15) and are regulated by extracellular matrix (ECM) interactions with integrin receptors (16) , which likely play an important role defining the polarity which defines b-cell organization in situ (17) . Fusion events in vitro also appear nonrandom in insulinoma cells and rodent b-cells, where exocytosis may occur at sites of recently fused vesicles (18) (19) (20) (21) (22) . Indeed, syntaxin1A and SNAP-25 cluster at sites of secretory granule docking and exocytosis in single β-cells (23, 24) and reduced SNAP-25 and syntaxin1A clusters correlate with impaired fusion (25). Also, fusion sites are localized to sites of Ca 2+ entry in b-cells, and this interaction is disrupted in b-cells from models of T2D (26, 27) and b-cells of human donors with T2D (28). The extent to which fusion events can repetitively occur at defined 'hotspots' on the b-cell membrane, the underlying mechanism for this, and its potential dysregulation in human T2D, remains unclear.
Among the ion channels that control b-cell function, the voltage-dependent L-type Ca 2+ channels increase intracellular Ca 2+ and trigger exocytosis (29). Repolarization of pancreatic β-cell action potentials is mediated by voltage-dependent K + (Kv) channels such as Kv2.1 (30).
Interestingly, Kv2.1 also forms multi-channel clusters at the plasma membrane (31) that directly facilitate efficient insulin exocytosis (19, 32, 33) , may also recruit SNARE complex proteins such as syntaxin1A, SNAP-25 and Munc18-1 (34), and serve as points of contact between the plasma membrane and endoplasmic reticulum (35). The channel regulates exocytosis independent of bcell electrical activity by binding syntaxin1A at its C-terminus (33, 36), a region that is modified by post-translational SUMOylation (37). A glucose-regulated deSUMOylation at the plasma membrane appears particularly important for the regulation of insulin secretion (38), and when stimulated can rescue exocytotic responses in human T2D b-cells (11).
Here we examined exocytotic responses from b-cells of 80 human donors with and without T2D. We demonstrate an impaired insulin secretion that can occur independent of a reduced islet insulin content in this cohort and confirm a single b-cell impairment in exocytotic function. By total internal reflection fluorescence (TIRF) microscopy and spatial analyses, we demonstrate a non-random distribution of fusion events across the cell membrane and show that this patterning is regulated by glucose and is disrupted in b-cells of donors with T2D. Knockdown of Kv2.1
reduces the spatial organization of these events, and we show that channel clustering controls the density of fusion 'hotspots' while the SUMOylation status of the channel at C-and N-terminal sites regulates the overall proportion of fusion events that occur at these sites. Finally, upregulation of Kv2.1 in T2D b-cells can convert a random distribution of fusion events into a compartmentalized pattern similar to that seen in b-cells of donors without diabetes.
RESULTS
Impaired spatial patterning of fusion in b-cells from donors with T2D
Glucose-stimulated insulin secretion is impaired from islets of donors with type 2 diabetes (T2D) (6, 39) . In a cohort of 80 human islet preparations (Suppl. Tables 1-2) we confirm that glucose-stimulated insulin secretion is impaired in T2D and show that this can occur without a reduction in insulin content (Fig 1A-B) . Although we (40) and others (39) have reported reduced islet insulin content from donors with long-standing T2D, the disease duration in these donors is relatively short (average 6.7 years, including some 'undiagnosed diabetes'). Donors with longer duration diabetes, or with higher HbA1c, tended to have lower islet insulin content (not shown).
In these donors we find that while increasing glucose facilitates exocytosis in b-cells from donors with no diabetes (ND), seen as a rightward shift in the distribution of exocytotic responsiveness of these cells (Fig 1C) , this is impaired in T2D (Fig 1D) consistent with reduced function at the level of single b-cells (11) .
Impaired exocytosis in models of T2D is associated with an uncoupling of exocytosis from sites of Ca 2+ entry (26, 27) and human T2D b-cells have a defect in glucose-dependent granule docking (12) . We performed live-cell total internal reflection fluorescence (TIRF) microscopy of single dissociated b-cells to assess the spatial relationship of fusion events in cells from a subset of ND and T2D donors. In this subset, we confirmed impaired insulin secretory function associated with T2D (Fig 1E) . To identify and perform spatiotemporal analysis of vesicle fusion, a MATLAB-based software (18) was applied to live-cell recordings obtained with over two minutes in a bath solution with 5 mM glucose, a concentration shown to facilitate insulin exocytosis (11) , following preincubation at 1 mM glucose for 30 minutes. Fusion events from ND b-cells had a higher degree of spatial organization than those observed in T2D b-cells, with numerous events appearing to occur repeatedly at 'hotspots' (Fig 1F-K ; Suppl Movie 1-2) within a defined area of 4x4 pixels determined by average vesicle diameter (see Methods). Each apparent hotspot was confirmed by generating event heat maps and comparing relative fluorescence to the first frame (Fig 1G,J) . The spatial organization of events was also confirmed by calculating Ripley's K-function values, which demonstrate a non-random distribution of these events (Fig 1H,K) . In ND b-cells 41.6% of events occur within spatially localized regions, while only 18.3% do so in T2D b-cells.
We confirmed impaired exocytosis by patch-clamp electrophysiology at 5 mM glucose (Fig   2A) . From the same donors, live-cell imaging of b-cells expressing NPY-EGFP to mark secretory granules (Fig 2B) at 5 mM glucose (following a 1 mM glucose pre-incubation) reveals that accumulated fusion events are decreased 56.1% in the T2D b-cells (Fig 2C) . Calculation of a Clustering Index (CI -see Methods) demonstrates that fusion events in the ND b-cells showed significant compartmentalization ('observation') compared with Monte Carlo simulation run 100 times of each cell assuming random distribution of events ('simulation'), or events in the T2D bcells which were seen to be no more organized than random simulation (Fig 2D) . While the above analyses account for differences in event frequency, we wished to confirm that the differential organization of events occurs independently of an overall decreased exocytosis since event frequency correlates with the proportion occurring at 'hotspots' (Fig 2E) .
Analysis of a sub-set of cells with equivalent exocytosis event frequency (dashed box and inset, Fig 2E) demonstrates that the proportion of events occurring at 'hotspots' (Fig 2F) and the density of these (Fig 2G) are decreased in T2D. Thus, impaired insulin secretion from islets of donors with T2D is associated with reduced exocytotic responses measured both by patch-clamp and live-cell imaging, and with an independent reduction in the compartmentalization of fusion events determined by generation of exocytotic heat maps, Ripley's K-function, Voronoi polygonderived Clustering Index, and cell sub-set analyses.
Glucose-dependent spatial patterning of exocytosis is impaired in T2D b-cells
In addition to its ability to initiate b-cell action potential firing, glucose signaling amplifies depolarization-induced insulin secretion and b-cell exocytosis (11, 41) . Glucose, but not direct depolarization with KCl, can diminish submembrane granule turnover in mouse b-cells (42). We stimulated b-cells with depolarizing KCl at either 1-or 5-mM glucose. Temporal analysis reveals that exocytosis is impaired in T2D b-cells under both conditions (Fig 3A, B) . At 1 mM glucose, the spatial uniformity of fusion events in ND b-cells was not different than that predicted by random simulation, but the compartmentalization of events increased in the presence of 5 mM glucose (Fig 3C) . Examining b-cells with equivalent rates of exocytosis in ND and T2D (Fig 3D, dashed box) , KCl-stimulated exocytosis at 5 mM glucose showed an increased proportion of fusion events at 'hotspots' (Fig 3E) , along with an increased density of these sites (Fig 3F) , effects that are blunted in b-cells of donors with T2D (Fig 3E-F) .
Observation of fusion occurring near sites of concurrent or recent membrane-resident granules
Insulin granule docking is a critical glucose-dependent step in insulin secretion, and is dysregulated in T2D (12) . Considering that glucose-stimulation recruits and KCl-stimulation depletes docking granules (43), together with our observation that glucose increases the proportion and density of 'hotspots', we hypothesized that membrane-associated granules may mark sites where repeated exocytosis occurs. Many fusion events throughout our recordings overlap with sites of membrane-resident granules observed at the initiation of imaging (Fig S1; Suppl Movie 3). As illustrated in Fig 4A ( and Suppl Movie 4) we observe fusion events that happen both around pre-docked granules and, later in the same recording, at this site after the pre-docked granule had fused. We have excluded events from this analysis that occur within very rapid (<1 s) succession directly overlaid with a docked granule (Fig 4B) since this may represent 'flickering' or 'kiss and run' of an individual granule.
Sequential fusion events are less often observed in T2D b-cells, which is dominated by isolated events (Fig 4C) . We find in ND b-cells (5 mM glucose) that 67.4% of fusion events occur at sites marked by membrane-associated granules present within the first frame of the recording, including the fusion of that docked granule itself, while only 55.2% of exocytosis in T2D b-cells occurs near such sites (Fig 4D) . Importantly, the overall density of membrane-associated granules is decreased 35.8% in T2D b-cells (Fig 4D) , which is consistent with a previous report (12) .
The density of membrane resident granules, and fusion 'hotspots', is controlled by Kv2.1
We demonstrated previously in insulinoma cells that the formation of multi-channel clusters of Kv2.1 controls the density of membrane-associated granules (32) and that fusion events occur on the periphery of Kv2.1 clusters (19) . Knockdown of Kv2.1 expression in human b-cells (Fig 5A) reduces the density of pre-docked secretory granules (Fig 5B) and the frequency of fusion events observed at 5 mM glucose (following a 1 mM glucose preincubation) (Fig 5C) but not the overall proportion of those events that occur near the pre-docked granules (Fig 5D) . The compartmentalization of fusion events, determined by calculation of Clustering Index, was not significantly reduced following Kv2.1 knockdown (Fig 5E) . Similar results are observed upon analysis of a subset of cells (dashed box, Fig 5F) with similar levels of exocytosis (Fig 5G) , where the proportion of exocytotic events occurring at hotspots was unchanged (Fig 5H) , but the overall density of these hotspots was decreased (Fig 5I) .
The formation of multi-channel clusters is required for the facilitation of b-cell exocytosis by Kv2.1 (19, 32) . Expression of a C-terminal truncated channel (Kv2.1-ΔC318) shown by us and others to be clustering-deficient (32, 44) in ND b-cells reduced the compartmentalization of fusion events (Fig 6A) . In a subset of ND cells with equivalent exocytosis (Fig 6B, dashed box) , upregulation of wild-type Kv2.1 did not effect the spatial organization of fusion events, while the Kv2.1-ΔC318 decreases proportion of events occurring at hotspots in ND b-cells (Fig 6C) without affecting the overall hotspot density compared with cells expressing mCherry alone (Fig 6D) . In T2D b-cells, up-regulation of the wild-type channel restored the spatial compartmentalization of events (Fig 6E-H) . We find that up-regulation of 'clustering-sufficient' wild-type Kv2.1 increases membrane-resident secretory granules by 30.0%, and increases exocytosis at these sites by 42.4% compared to the mCherry control group in ND donors (Fig S2A) . Similarly, in T2D donors the wild-type Kv2.1, but not the 'clustering deficient' Kv2.1-DC318, can increase membraneassociated granules by 37.5% and increase fusion events around these by 50% (Fig S2B) .
SUMOylation sites on Kv2.1 determine the proportion of fusion events occurring in hotspots
The clustering of Kv2.1 contributes to the spatial coordination of fusion events secondary to the control of membrane-resident granule density. We (45) and others (37) (Fig S3B) . Mutation of K145 does not appear to alter Kv2.1-mediated K + currents (37), which we confirm (Fig 7A, B) . However, loss of the K145 SUMOylation site (Kv2.1-K145R) blunts the suppressive effect of SUMO1 on exocytosis in insulinoma cells (Fig   7C-F ) and when combined with abolishing the K470 SUMOylation site (Kv2.1-K145/470R) completely prevents SUMO1-dependent suppression of exocytosis (Fig 7F) .
In human b-cells from donors without diabetes, increasing SUMO1 reduces the compartmentalization of fusion events (Fig 8A,B) . Loss of Kv2.1 SUMOylation sites in the Kv2.1-K145/470R double mutant prevents this (Fig 8C,D) . We find that SUMO1 reduces the compartmentalization of events such that the Clustering Index is no longer different from random simulations and this is completely prevented in the Kv2.1-K145/470R group (Fig 8E) .
Finally, in cells with equivalent rates of exocytosis (Fig 8F, dashed box) , SUMOylation of Kv2.1 reduces the proportion of fusion events occurring within hotspots (Fig 8G) with only minimal impact on total hotspot density (Fig 8H) . Altogether, we find that multi-channel Kv2.1 clusters promote the recruitment of membrane-resident secretory granules which define sites of compartmentalized fusion. The actual targeting of granules to these sites depends on deSUMOylation of the channel (Fig S4) .
DISCUSSION
The regulated exocytosis of insulin from human pancreatic b-cells is impaired in T2D. An insulin secretory deficit, including a reduced responsiveness to glucose, is an important determinant of T2D development and progression (51). While impaired islet mass may contribute to reduced insulin secretion in T2D, at least later in the disease (5), the contribution of reduced islet insulin content versus impaired secretory responses early in T2D progression is less well recognized. Although insulin content has been shown to be decreased in T2D human islets by us (40) and others (39), in the present data-set we observed impaired insulin secretory responses without an obvious decrease in insulin content. This is likely due to the relatively short duration of T2D in this cohort (6.7 +/-1.9 years) where only 5/17 donors had reported disease duration of 10 years or more. Of the T2D donors with no information on disease duration, one appeared well-controlled (HbA1c 6.2) and the other was managed with diet only. One additional dietcontrolled T2D donor (R198) diagnosed 10 years prior may be considered in remission based on available information (see Methods). Although this donor-to-donor heterogeneity could complicate the interpretation of secretion results, which is the case for all human islet studies, in this paper we have taken a step forward in addressing this by linking each preparation used to its full donor, quality control, and islet function data via a web tool (www.isletcore.ca) and hyperlinks provided in Supplementary Tables 1 and 2 .
Single-cell impairments in insulin exocytosis from human T2D b-cells (11, 32) may result from reduced glucose-dependent granule docking (12) and disrupted localization of granule fusion to sites of Ca 2+ entry (26-28). Previous studies have suggested both directional control of insulin release towards the vasculature in situ (13) (14) (15) and the existence of repetitive release sites (18) (19) (20) (21) (22) . Focal adhesion activation may contribute to this (52), resulting from ECM-dependent interactions that drive cell polarity in situ (17) . While it seems likely that the additional signals SNARE proteins and ion channels are compartmentalized across the cell membrane, in complexes which are generally thought to facilitate efficient exocytosis. Previously, we reported that Kv2.1 in pancreatic b-cells co-localizes with docking granules (19, 32) and directly facilitates exocytosis independent of its electrical function (36) in a manner that is dependent upon the formation of multi-channel clusters (32). Indeed, we recently demonstrated that fusion events in insulinoma cells occur adjacent to Kv2.1 clusters (19) and suggested that these sites act as 'reservoirs ' for the provision of release-competent granules. This role is supported by our observation that depletion or over-expression of Kv2.1 reduces or increases, respectively, the density of membrane-resident granules and consequently the density of fusion hotspots (Fig S4) .
These manipulations have little or no effect on the overall proportion of total fusion events occurring within these hotspots, suggesting that while clustered Kv2.1 channels contribute to setting the number of hotspots another mechanism is involved in directing fusion to these sites.
SUMOylation is an important regulatory mechanism for membrane proteins. Kv2.1 can by SUMOylated (37, 45), and we find an important functional effect of manipulating SUMOylation sites in both the N-and C-terminus of the channel. The N-terminal SUMOylation site is less well established and has no apparent impact on the biophysical function of K + conductance, in line with a previous report (37). We do however find that this is more highly conserved between species and amongst Kv isoforms. This site in Kv1.5 has a demonstrated function in SUMO-control of the channel (48) and here we show that mutation of the consensus lysine residue (K145)
reduces the inhibitory effect of SUMOylation on exocytosis in concert with the C-terminal site (K470). This has only minimal impact on the density of hotspots, but instead controls the occurrence of fusion at these sites (Fig S4) . It seems that Kv2.1 SUMOylation, which occurs at sites of syntaxin-1A/-3 (53) and SNAP-25 (47) binding might not alter the ability for granules to be recruited to the 'reservoir', but instead impacts the transfer of granules to the fusion sites.
This, and the roles in sequential insulin granule fusion for Munc18b (20) and syntaxin-3 (54), which bind the channel (19) , suggest that the likely mechanism for the sequential fusion at hotspots involves Kv2.1 interactions with an alternate SNARE complex.
In summary, we demonstrate a glucose-dependent spatiotemporal compartmentalization of insulin granule fusion events in human b-cells. This contributes to the amplification of insulin exocytosis by glucose and is perturbed in T2D. The voltage-gated K + channel Kv2.1 plays a structural role in this process, possibly as a component of a complex serving as a 'reservoir' of granules for future fusion. Multi-channel clusters of Kv2.1 sets the density of these 'hotspot platforms', while deSUMOylation of the channel determines the progression of insulin granules to fusion-competence at these sites.
METHODS
Human islets and cell culture. Human islets were isolated at the Alberta Diabetes Institute
IsletCore according to procedures deposited in the protocols.io repository (55). A total of 63 donors with no-diabetes (ND; Suppl Table 1 ) and 17 donors with type 2 diabetes (T2D; Suppl Table 2 ) were examined in this study. Extended donor, organ processing, and quality control boundaries. Exocytosis hotspots, recognized by MATLAB, was run with a threshold value of 0.6328 µm, which is <4 pixels and represents the minimum resolvable distance to distinguish two granule fusion sites in our system. The '% of events at hotspots' was calculated as the number of fusion events occurring at hotspots divided by the total fusion events and multiplied by 100. The 'hotspot density (#/100 µm 2 ) was calculated as the number of hotspots normalized to cell footprint area. Hotspots visualization heat maps were generated through interpolation (MATLAB 'v4' interpolation method) using number of events as the third dimension on a 1-pixel resolution grid. G-H) SUMO1 reduced the proportion of events occurring at hotspots (G) with little impact on the overall hotspot density (H). Significance was determined by ANOVA followed by Bonferroni posttest.*p<0.05, **p<0.01 and ***p<0.001. 
Statistical analysis. Data analysis was performed using
